Europe needs a vibrant research eco-system Europe needs a vibrant research eco-system At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.
Annual Results Press Conference Annual Results Press Conference Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year.
Nagoya Protocol Nagoya Protocol At Boehringer Ingelheim, environmental consciousness and protection are priorities in everything we do.
Green Chemistry Green Chemistry Green Chemistry is critical for us as it balance the long-term sustainability of business, society, and the environment.
On two wheels for more animal health On two wheels for more animal health Cowtribe’s social entrepreneurs win Boehringer Ingelheim's Accelerator Program.
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio
Combating food insecurity for more health equity in the U.S. Combating food insecurity for more health equity in the U.S. Meet social innovation founder Katie at Making More Health Together 2023: How the social innovation founder brings fresh food stores back to the U.S.
Lead with Pride – for the Benefit of All. Lead with Pride – for the Benefit of All. How Inclusive Leadership advocates for Acceptance and creating a Sense of Belonging
Experiences of living with cancer Experiences of living with cancer We know from speaking with people living with cancer and their loved ones, that it’s often the small moments that can be the most significant.
Advancing green chemistry for more sustainable medicines Advancing green chemistry for more sustainable medicines By applying the principles of eco-design and green chemistry, we developed an innovative manufacturing process with reduced environmental footprint.
"Medical innovations and healthcare for everyone" "Medical innovations and healthcare for everyone" African Americans are often excluded from healthcare options and medical innovations. We want to learn how we can better serve them.
Plasmid DNA Production | BioXcellence Plasmid DNA Production | BioXcellence Discover our range of plasmid DNA production solutions from research to GMP.
Animal Health Partnering Contacts Animal Health Partnering Contacts Partnership and diversity of thought are powerful drivers of innovation. If you have a project you would like to discuss please reach out to us.
More health in vulnerable communities More health in vulnerable communities In an era of globalization and social connectivity, one-dimensional solutions often do not work anymore. Complex challenges need complex solutions.
Lady, a guide dog in the office Lady, a guide dog in the office A great partnership between a Boehringer Ingelheim employee and her guide dog at work. Their relationship goes beyond the human-animal bond.
Championing life-science innovators and entrepreneurs Championing life-science innovators and entrepreneurs The Boehringer Ingelheim partnering team talks about Grass Roots innovation and the programs that are available to support life-science innovators.
Looking behind the scenes of Afrika Kommt! Looking behind the scenes of Afrika Kommt! Looking behind the scenes of Afrika Kommt! with Sabine and Eunice. I in D&I audio interview with reflections on a program designed to build bridges.
S&P Animal Health Partnering Oct 2023 S&P Animal Health Partnering Oct 2023 Interview by S&P Global with Megan Grether, discussing Boehringer Ingelheim Animal Health Partnering’s ambition and approach
Kicking off 2024 with five new R&D partnerships Kicking off 2024 with five new R&D partnerships We are kicking off 2024 with five new R&D partnerships to further enable and accelerate the company’s commitment to transform the lives of patients world-wide.